arXiv:2503.03486cs.LGcs.CR2025-03ICLR被引 5

保护隐私的同时精准估计药物效果差异

Differentially Private Learners for Heterogeneous Treatment Effects

  • 基于奈曼正交损失函数设计隐私保护框架
  • 在合成与真实数据上验证了模型有效性
  • 适合医疗数据分析中需严守隐私的研究者

患者数据广泛用于评估药物的异质性治疗效果,但包含高度敏感信息,必须严格保护隐私。本文提出DP-CATE框架,在差分隐私约束下估计条件平均处理效应(CATE)。该框架具备奈曼正交性,适用于任意两阶段CATE元学习器及任意机器学习模型进行扰动估计。进一步扩展中,采用再生核希尔伯特空间(RKHS)回归,实现对完整CATE函数的隐私释放。在合成与真实世界数据集上的实验验证了其有效性。据我们所知,这是首个兼具奈曼正交性与差分隐私的CATE估计框架。

原文摘要 · Abstract (English)

Patient data is widely used to estimate heterogeneous treatment effects and thus understand the effectiveness and safety of drugs. Yet, patient data includes highly sensitive information that must be kept private. In this work, we aim to estimate the conditional average treatment effect (CATE) from observational data under differential privacy. Specifically, we present DP-CATE, a novel framework for CATE estimation that is Neyman-orthogonal and further ensures differential privacy of the estimates. Our framework is highly general: it applies to any two-stage CATE meta-learner with a Neyman-orthogonal loss function, and any machine learning model can be used for nuisance estimation. We further provide an extension of our DP-CATE, where we employ RKHS regression to release the complete CATE function while ensuring differential privacy. We demonstrate our DP-CATE across various experiments using synthetic and real-world datasets. To the best of our knowledge, we are the first to provide a framework for CATE estimation that is Neyman-orthogonal and differentially private.

隐私计算因果推断医疗AI

Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。